Hodges Capital Co. acquired new stake in NuVasive during Q4 — 4 notes

Spinal Tech

Shares of NuVasive, a medical device company based in San Diego, traded down 1.94% earlier this week.

Here are four things to know:

 

1. Dallas-based Hodges acquired 186,425 shares of NuVasive's stock, which is valued at approximately $12,558,000 in the fourth quarter of 2016.

 

2. NuVasive's shares traded down 1.94 percent earlier this week, reaching $69.32.

 

3. The company's 12-month low is $36.81 and their 12-month high is $71.10. Its 50-day moving average price is $67.96 and its 200-day moving average price is $64.80.

 

4. NuVasive creates minimally disruptive surgical products and works on developing solutions for spinal ailments.

 

More articles on devices:

WishBone hires former Congressman Marlin Stutzman as president — 4 takeaways

Mainstay Medical's first ReActiv8 implanted in Germany — 5 observations

Medtronic plans to sell medical supplies unit, Bloomberg reports: 6 key insights

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers